Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4

INTRODUCTION: Dual therapy (PegIFN and ribavirin) (DT) was the standard of care in patients infected with HCV genotype 4 (HCV-4) until 2014. Nowadays, new treatment options are available including interferon (IFN)-based and other IFN-free regimens. AIM: To assess the efficacy (SVR24) and safety of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozielewicz, Dorota, Grabińska, Anna, Madej, Grzegorz, Wietlicka-Piszcz, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894449/
https://www.ncbi.nlm.nih.gov/pubmed/29657607
http://dx.doi.org/10.5114/pg.2018.74558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894449/
https://www.ncbi.nlm.nih.gov/pubmed/29657607
http://dx.doi.org/10.5114/pg.2018.74558

Ejemplares similares